Company profile: Alcedis
1.1 - Company Overview
Company description
- Provider of digital clinical research services, including comprehensive trial management from phase I to approval, real-world evidence collection, and scientific consulting. Delivers platforms for multi-channel data integration with customized eCRFs, mobile applications, and big data interfaces, plus regulatory-compliant study design, technology integration to maximize data quality, and full study conduct.
Products and services
- Alcedis Platforms: Engineers multi-channel technology for clinical study data integration, featuring customized eCRFs, mobile applications, and big data interfaces, multi-channel
- Digitalized Clinical Research: Delivers comprehensive clinical trial services spanning phase I to drug approval, including real-world evidence collection, with a flexible module-based service concept tailored to project structures, module-based
- Study Case Design: Architects regulatory-compliant study concepts, forecasts study courses, and plans budgets to align trial design with requirements and resources, regulatory-compliant
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alcedis
Aitia
HQ: United States
Website
- Description: Provider of Causal AI and digital twin-based drug discovery solutions. Offers Gemini Digital Twins—computational disease models that simulate genetic and molecular interactions to identify novel drug targets and patient subpopulations—and Causal AI Drug Discovery leveraging multi-omic data to accelerate development of new therapies for neurodegenerative diseases and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aitia company profile →
Evidation
HQ: United States
Website
- Description: Provider of a platform that measures health in everyday life and enables anyone to participate in research and health programs, built on user privacy and control over permissioned health data. Through its Achievement platform, trusted by millions, it generates data with unprecedented speed, scale, and rigor to support better health outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evidation company profile →
Insilico Biotechnology
HQ: Germany
Website
- Description: Provider of bioprocess software and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insilico Biotechnology company profile →
Prosarix
HQ: United Kingdom
Website
- Description: Provider of computational approaches and products to assist drug discovery for biotech and pharmaceutical sectors, including ProtoDiscovery, a validated, state-of-the-art computational platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prosarix company profile →
CureClick
HQ: United States
Website
- Description: Provider of a proprietary, community-powered crowdsourcing platform that accelerates awareness and participation in clinical research and improves patient recruitment for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CureClick company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alcedis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alcedis
2.2 - Growth funds investing in similar companies to Alcedis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alcedis
4.2 - Public trading comparable groups for Alcedis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →